Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOLEGEND, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-05 to 2023-09-29
Current total value of award: $21586.5
Description: BIOLEGEND TOTALSEQ ANTIBODIES (AMBIS 2177674)